Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic Study of TS-071 in Type 2 Diabetes Mellitus Patients With Renal Dysfunction
jRCT2080221237Phase 2
- Sponsor
- Taisho Pharmaceutical
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of luseogliflozin in type 2 diabetes mellitus (T2DM), chronic kidney disease (CKD), sponsored by Taisho Pharmaceutical.
02
Drugs
luseogliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)chronic kidney disease (CKD)
Beyond the preview
Go deeper on jRCT2080221237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221237.